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anhydride/pyridine (1:9 v/v) was added to the resin. After shaking for 3 min the resin was washed with DMF (× 5), DCM (× 5) and DMF (× 5). Azidoglycine coupling: A pre-activated solution of azidoglycine 15 (4 eq.), PyBOP (4 eq.) and NMM (8 eq.) in DMF (final concentration 0.1 M) was added to the resin. After shaking for 1 h, the resin was washed with DMF (× 5) and DCM (× 10) and the capping step omitted.
Cleavage: A mixture of TFA, triisopropylsilane (TIS) and water (90:5:5 v/v/v) was added to the resin. After shaking for 1.5 h, the resin was washed with TFA (3 × 2 mL)
Work-up:
The combined cleavage solution and TFA washings were concentrated in vacuo. The residue was dissolved in water containing 0.1% TFA and purified by preparative HPLC (Gradient 0 to 25% B over 60 min).
Novel compounds are denoted in italics.
Synthesis of alkynyl-tetrapeptide 9.
Wang resin was pre-loaded with Fmoc-Ala-OH and the tetrapeptide assembled using the iterative peptide assembly protocol described above. Propiolic acid coupling: A pre-activated solution of propiolic acid (8 eq.), EEDQ (8 eq.) in DMF (final concentration 0.1 M) was added to the resin. After shaking for 1 h, the resin was washed with DMF (× 5) and DCM (× 10) and the capping step omitted. Cleavage: A mixture of TFA, triisopropylsilane (TIS) and water (90:5:5 v/v/v) was added to the resin. After shaking for 1.5 h, the resin was washed with TFA (3 × 2 mL) Work-up:
The combined cleavage solution and TFA washings were concentrated in vacuo. 
Synthesis of azido-PAMAM dendrimer core 12
PAMAM dendrimer, ethylenediamine core, generation 0.0 (1.0 mL of a 20 wt. % solution in methanol, 0.4 mmol) was added to a stirred suspension of potassium carbonate (0.40 g, 3.1 mmol) and copper sulfate pentahydrate (40 mg, 0.2 mmol) in methanol (1 mL). Imidazole-1-sulfonyl azide hydrochloride salt (11) [2] (0.4 g, 1.9 mmol) was then added and the reaction stirred at rt for 1 h. The insoluble potassium salts were filtered and the filter washed with methanol. 
Synthesis of peptide dendrimer 13
Azido-dendrimer core 12 (1 mg, 1.6 µmol, 1 eq.) and alkynyl-tetrapeptide 9 (3.7 mg, 9.6 µmol, 6 eq.) were dissovled in t-butanol/water 1:1 (v/v) (100 µL 
Synthesis of azidoglycine 15
A solution of methyl bromoacetate (0.80 mL, 8.5 mmol) and sodium azide (0.60 g, 9.0 mmol, 1.1 eq.) in DMF (5 mL) was stirred at room temperature for 2.5 h. The reaction mixture was diluted with water (50 mL) and extracted with diethylether (4 x 10 mL). The combined organic fractions were washed with water (4 x 10 mL), dried (Na 2 SO 4 ) and concentrated in vacuo to obtain azidoglycine methyl ester as a yellow oil (235 mg, 24%) which was used without further purification. Potassium hydroxide 
Synthesis of azidopeptides 14 and 26 and azido-glycopeptide 18
Tetrapeptide (14)
Tetrapeptide 14 was synthesised using the iterative peptide assembly described above. 
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Synthesis of peptide dendrimer 24
Alkynyl-dendrimer core 23 (0.9 mg, 1.0 µmol, 1 eq.) and azidopeptide 14 (4.3 mg, 12
µmol, 6 eq.) were dissovled in t-butanol/water 1:1 (v/v) (100 µL). 
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Synthesis of glycopeptide dendrimer 25
Alkynyl-dendrimer core 23 (0.9 mg, 1.0 µmol, 1 eq.) and azido-glycopeptide 18 (3. 
S15
Synthesis of peptide dendrimer 28
Alkynyl-dendrimer core 23 (0.9 mg, 1.0 µmol, 1 eq.) and azidopeptide 26 (7.7 mg, 
